Gemini Bio
About Gemini Bio
Gemini Bio is a Healthcare company based in West Sacramento (United States) founded in 1985, and was acquired by BelHealth Investment Partners in September 2018. Supplement reagents for cell and gene therapy are manufactured. The company has 79 employees. Gemini Bio has completed 1 acquisition, including Orflo. Its chief executive, as recorded, is Brian Parker. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its competitors include MaxCyte, SQZBiotech and Fluxion Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Gemini Bio was established in 1985 in West Sacramento, United States. Custom media, animal and human sera, buffers, and other supplement reagents are produced by the company for use in academic research, biotechnology, cell and gene therapy, and biopharma sectors. These materials are distributed to scientific communities worldwide to support research and development activities in life sciences.
- Headquarters West Sacramento, United States
- Employees 79
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website geminibio.com
- Social LinkedIn Facebook
- Acquired by BelHealth Investment Partners (Sep 2018)
- Latest Funding Round$5.68M (USD), Unspecified
May 2024
- InvestorsBroadoak Capital Partners
& 1 more
- Employee Count79
- Investments & Acquisitions
- Acquired byBelHealth Investment Partners
(Sep 2018)
Funding Insights of Gemini Bio
- Total Rounds 2
- Last Round Unspecified — $5.68M
- First Round $18.5M
(Nov 2021)
- Investors Count 1
All 2 funding rounds of Gemini Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $5.68M | Unspecified | – | – | – |
| Nov 2021 | $18.5M | Debt – Conventional | – | – |
2 investors in total: 2 institutional.
Investors in Gemini Bio
Gemini Bio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Broadoak Capital Partners and BelHealth Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in healthcare businesses, focusing on services, products, and distribution. | belhealth.com | |||
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States |
Investor details for Gemini Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gemini Bio
9 people are tracked at Gemini Bio (6 in leadership, 3 in team); the tracked headcount is 79.
| Name | Role | Group |
|---|---|---|
Steven Sandoval Sr | Board of Directors | Leadership |
Brian Parker | CEO | Leadership |
Ed Mendham | CFO | Leadership |
Justin Henson | EVP - Chief Development Officer | Leadership |
David Terry | Vice President Of Sales, Process Liquid Solutions | Leadership |
Kim (EK) Thompson | Director Of Marketing | Leadership |
Celeste Robinson | Controller | Team |
Orysya Bezverhniy, CPA | Financial Analyst, Cost | Team |
Megha Khalasi | QA Manager | Team |
Complete people profiles for Gemini Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gemini Bio
Gemini Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orflo.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Instrumentation for cell and protein analysis is developed and marketed. | orflo.com | Ketchum, United States | 2003 | Nov 2019 | •••• |
Complete acquisition details for Gemini Bio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Gemini Bio
5 dated milestones of Gemini Bio across 39 years, from founding to its latest funding, stage changes and deals.
- Founded Gemini Bio is founded.
- Exit Acquired by BelHealth Investment Partners.
- Acquisition Acquires Orflo.
- Funding First funding round of $18.5M.
- Funding Latest funding round, Unspecified, of $5.7M.
Competitors of Gemini Bio
Gemini Bio has 3 listed competitors in our database, 3 of them funded. They include MaxCyte, SQZBiotech and Fluxion Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| maxcyte.com | 1998 | Gaithersburg, United States | $20.69M | 71 | Instrument systems for cell processing and modification are provided. | |
| sqzbiotech.com | 2013 | Boston, United States | $167.41M | 117 | Cell therapies are developed using proprietary Cell Squeeze technology. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | Microfluidics-based tools for cellular analysis are provided. |
Detailed competitors of Gemini Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gemini Bio
The website of Gemini Bio (geminibio.com) receives about 7.9K visits a month.
- Monthly visits7.9K
▼ 23.3% vs previous month
Websites whose visitors overlap most with Gemini Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| celltreat.com | 100% | 35.5K | #913,697 | View details | |
nilesbio.com | nilesbio.com | 100% | – | ||
| beckmancoulter.com | 91% | 113.9K | #341,469 | View details | |
| novogene.com | 83% | 366.1K | #104,051 | View details | |
| genscript.com | 63% | 456.1K | #94,888 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Gemini Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Gemini Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gemini Bio
Complete news archive for Gemini Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gemini Bio
Gemini Bio was founded in 1985 and raised its 1st funding round 36 years after it was founded.
Gemini Bio is headquartered in West Sacramento, United States. It is registered at West Sacramento, California, United States.
Brian Parker is the CEO of Gemini Bio, as recorded in our data.
Gemini Bio has 79 employees.
Gemini Bio was established in 1985 in West Sacramento, United States. Custom media, animal and human sera, buffers, and other supplement reagents are produced by the company for use in academic research, biotechnology, cell and gene therapy, and biopharma sectors. These materials are distributed to scientific communities worldwide to support research and development activities in life sciences.
Gemini Bio's top competitors include MaxCyte, SQZBiotech and Fluxion Biosciences.
Gemini Bio has made 1 acquisition, including Orflo.
Gemini Bio has 2 investors. Key investors include Broadoak Capital Partners, and BelHealth Investment Partners.
Yes. Gemini Bio was acquired by BelHealth Investment Partners in September 2018.